PROC Stock Price, Chart, Stats & News

Procaps Group S.A.
Save
Procaps Group S.A. (PROC) does not currently pay a dividend.
102.08M
Market cap
1.53x
Current P/E
81.30x
Forward P/E
PROC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 58.44% |
Operating margin | 12.76% |
Pretax margin | 12.86% |
Net margin | 10.38% |
Effective tax rate | 19.29% |
ROA | 9.24% |
ROE | -221.90% |
D/E | -303.86x |
Interest coverage ratio | 2.03x |
PROC valuation
P/E | 1.53x |
P/S | 0.25x |
P/B | -108.52x |
P/CF | 7.24x |
P/FCF | -5.84x |
P/OCF | 7.24x |
PEG | 0.02x |
EV multiple | -1.48x |
About
Procaps Group S. A., established in Luxembourg in 1977, functions as a global pharmaceutical enterprise dedicated to the creation, production, and distribution of a broad spectrum of pharmaceutical solutions. The company manufactures and markets branded prescription medications addressing diverse therapeutic needs, including women's health, pain management, dermatological conditions, digestive disorders, growth and development, cardiovascular care, vision health, central nervous system ailments, and respiratory issues.
Similar securities
Based on sector and market capitalization
Report issue











